Operational profit after tax rose 38.6% YoY to Rs 128.2 crore in Q3 FY26 from Rs 92.5 crore a year ago. On a sequential basis, operational PAT declined 8.6% QoQ from Rs 140.3 crore.
Revenue increased 3.6% YoY to Rs 1,194.6 crore in Q3 FY26 compared with Rs 1,153.7 crore in Q3 FY25. Sequentially, revenue declined 2.1% QoQ from Rs 1,220.8 crore. Revenue was impacted by low offtake in the institutional business and flattish US operations.
Gross profit rose 8.6% YoY to Rs 731.7 crore from Rs 673.5 crore. Gross margin expanded sharply to 61.2%, an improvement of 280 bps YoY and 340 bps QoQ.
EBITDA increased 12.2% YoY to Rs 235.9 crore in Q3 FY26 from Rs 210.3 crore, while rising 1.9% QoQ. EBITDA margin improved to 19.8%, up 160 bps YoY and 80 bps sequentially.
Ex-US market revenue stood at $64 million, registering a strong 20% YoY growth. Growth was led by other regulated markets and growth markets, which helped offset weak institutional demand and flat US performance. Management reiterated continued investments in sustainable long-term growth and announced the appointment of Peter Hardwick as CEO of the North America business.
Strides Pharma Science is a Bengaluru-headquartered global pharmaceutical company focused on regulated and emerging markets, with manufacturing facilities across India, Italy, Kenya and the US, and a presence in over 100 countries.
"Prevent unauthorised transactions in your account ; Update your mobile numbers/email IDs with Us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day” - Issued in the interest of Investors"
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
"No need to issue cheques by investors while subscribing to Equity IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."